i-Pharm Consulting

A massive congratulations to our Associate Director, Oliver Morkel for being recognized as the i-Pharm UK-EU Top Biller for Q3! We’re proud to highlight the achievements of our outstanding team members, and Ollie has truly excelled with his hard work and dedication this quarter. With exceptional feedback from both candidates and clients on Ollie's work, it’s no surprise he was able to achieve this. Leading a team while excelling in his own space is no easy feat, well done again!

With the Federal Reserve’s recent interest rate cut, the life sciences sector is looking at new avenues for growth and opportunity, but also some potential challenges. 🧬 Here’s are some areas where this financial shift may positively impact the industry: 1. Boost innovation and future investment 2. Accelerate M&A activity 3. Create opportunities for further investment in infrastructure and talent ____________ Interested in how we see these impacts coming into play in the industry? Turn on post notifications to be alerted when the next edition of i-Pharm Insights is released, where we discuss the Feral Reserve's interest rate cut in further detail. 🔔 #iPharm #FederalReserve #iPharmInsights

Reflecting on our 2023 predictions for data analytics in life sciences, we've seen some remarkable advancements. Now looking ahead, here's what we anticipate for data analytics in life sciences by 2025: 1️⃣ With AI already reducing development timelines by 30% and costs by 20%, we expect even greater efficiencies as AI technologies become more sophisticated and integrated into the drug development pipeline. 2️⃣ Building on the current use of AI to predict readmissions and optimise patient flow, 2025 will likely see more personalised and precise patient care, driven by real-time data analytics. 3️⃣ As real-time analytics continue to enhance R&D, marketing and compliance, we predict a more agile, data-driven approach to business strategy and operations, further driving success in the life sciences sector. ______________ What advancements are you most looking forward to in the coming year? Vote in the poll below! 📊 #dataanalytics #lifesciences #2025 #iPharm

In 2023, we wrote a blog post about the future of data analytics in the life science industry. 📊 Now, 18 months later, we wanted to look back at the predictions we made and look at the current state of the market to see how these matched up. Take a look through the slides below to see how our predictions compared to what is happening now for data analytics in the life science industry! 📈 ____________ See the original blog post by i-Pharm Consulting here: 🔗 https://lnkd.in/ehwYQAke #lifesciences #bigdata #iPharm

The life sciences industry is expecting some 133,000 new jobs by 2030! 🚀 So, how can companies effectively attract and retain the skilled professionals they need to thrive? As the sector expands, it's important for companies to reconsider how they approach hiring, by prioritising building strong employer brands, fostering inclusive work environments and leveraging innovative recruitment technologies to stay competitive. ________________ Read the full article from i-Pharm on this topic here: 🔗https://lnkd.in/e43cEeAT #raredisease #recruitmentagency #iPharm 

Did you know there are over 10,000 known rare diseases, affecting millions worldwide? It’s important to support the researchers working hard to find solutions to improve lives. 🌍 Here's how we can make that happen: 1️⃣ Fuel their expertise: Provide access to cutting-edge training, scientific databases and key journals. 2️⃣ Drive discovery: Equip them with the latest technologies and medical devices. 3️⃣ Share their successes: Support them in securing funding and publishing their findings to accelerate progress. Take a look at our blog post that takes a deeper look into these roles: 🔗 https://lnkd.in/eNHWJV9q #iPharmGxP #lifesciences #rarediseases

Last week, we were taking a look at clinical trials and the importance of data quality in early-stage trials. 📈 We asked you what you think the biggest challenge in early-state clinical trials is and the results are in! With 37% of you voting that ensuring high-quality data is the biggest challenge, and 31% voting for consistency across trial sites, it is clear that opinions are divided and both these areas are of high importance during early stages. _____________ What do you think about these results? Leave your thoughts in the comments below! 💭 #iPharm #clinicaltrial #lifesciences

Today is World Mental Health Day 2024. 🌍 Here are some tips on how to nurture your mental wellbeing in the workplace: 🧘♂️ Practise mindfulness 🏋️♀️ Prioritise your physical health 😴 Make sure you're getting enough sleep 🎉 Celebrate wins 👯♂️ Make sure you have a good support system in place Take a look through the slides below to read more about the benefits of each of these mindful habits. ⬇️ ___________ If you are struggling with your mental health, make sure to talk to someone close to you and seek the help you require. #worldmentalhealthday2024 #mentalhealth #iPharm

Victor Ambros and Gary Ruvkun received the Nobel Prize in Physiology or Medicine 2024 this week for their groundbreaking work with microRNAs. 🧬 Their work revealed how microRNAs allow cells to express genes differently, which is crucial for the diversity of cell functions within an organism. MicroRNAs, found to number over a thousand in the human genome, are essential in the development of multicellular life. MicroRNAs have helped enable the evolution of complex life-forms as without them, every cell in an organism would be identical. ________________  Do you see this work driving innovation in our industry? Leave your thoughts in the comments below. 💭 #microRNA #NobelPrize #iPharm

What are the benefits of hiring an in-house quality assurance specialist? 🤔 Hiring an in-house Quality Assurance Specialist is crucial for pharmaceutical firms to enhance product quality, ensure compliance and maintain brand reputation. With deep industry knowledge, these specialists drive continuous improvement, conduct internal training and support regulatory adherence, ultimately improving customer satisfaction and reducing risks of costly recalls. Investing in QA expertise can lead to competitive advantage and sustainable growth. If you’re considering strategic growth, hiring a dedicated QA specialist is a step toward excellence. ⭐️ ____________ Read our full blog post on the topic here: 🔗 https://lnkd.in/efkpMxVm #qualityassurance #iPharm #QAspecialist